Abstract:
There has been increasing interest and investigation into the quality of life parameter in the assessment of chronic disease. There are no quality of life assessment instruments specific to Systemic Lupus Erythematosus in the Portuguese language.
Therefore, we translated into Portuguese, culturally adapted and assessed the reliability and validity of the Systemic Lupus Erythematosus Quality of Life (SLEQOL) and Systemic Lupus Erythematosus Symptom Checklist (SSC) questionnaires.
We studied 107 patients with lupus (according to ACR criteria) over 16 years of age who responded to the SLEQOL, SSC and SF-36 during four visits over the course of 1 year with the aim of translating the instruments and determining their psychometric properties. Following the authorization from the respective authors, translation and cultural adaptation of the questionnaires into the Portuguese language was performed in accordance with studies on questionnaire translation methodology. Reliability was analyzed through three interviews with different interviewers: two on the same day (inter-observer) and a third interview conducted by one of the interviewers within 14 days of the first evaluation (intra-observer). Validity was assessed through correlations between clinical and quality of life parameters as assessed by the SLEQOL and SSC. Descriptive analysis was performed for the characterization of the sample. The intraclass correlation coefficient was used to assess intra-observer and inter-observer reproducibility. Internal consistency of the items was assessed using Cronbach’s alpha coefficient. Pearson’s correlation coefficient was used to study validity. The level of significance for all statistical tests was set at 5%.
The main results obtained for the SLEQOL were a 0.807 correlation coefficient for internal consistency for all questions and domains as well as a 0.990 inter-observer and 0.969 intra-observer correlation coefficient. The correlation coefficients for internal consistency, intra-observer reliability and inter-observer reliability for the SSC were 0.874, 0.925 and 0.917, respectively. In the validation, both the SLEQOL and the SSC demonstrated a moderate correlation with the SF-36, but a low correlation with disease activity and damage.
The SLEQOL and SSC are broad-based, easily administered questionnaires. The SLEQOL performs well in assessing physical symptoms and the mental status and wellbeing of patients. Both instruments are robust, exhibiting reliability and validity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACR:
-
American College of Rheumatology
- Anti-dsDNA:
-
anti-double strand deoxyribonucleic acid antibody
- BILAG:
-
British Island Lupus Assessment Group
- SD:
-
standard deviation
- ANA:
-
anti-nuclear antibody
- IL:
-
interleukin
- SLE:
-
systemic lupus erythmatosus
- LUPUSQOL:
-
lupus quality of life
- Mex SLEDAI:
-
Mexican systemic lupus erythematosus disease activity index
- WHO:
-
World Health Organization
- OMERACT:
-
Outcome measures in rheumatology clinical trials
- PROs:
-
patient-reported outcomes
- QOL:
-
quality of life
- SF-36:
-
medical outcomes study 36-item short-form health survey
- SLAM:
-
systemic lupus activity measure
- SLE:
-
systemic lupus erythematosus
- SLEDAI:
-
systemic lupus erythematosus disease activity index
- Modified SLEDAI-2K:
-
modified systemic lupus erythematosus disease activity index
- SLENQ:
-
systemic lupus erythematosus needs questionnaire
- SLEQOL:
-
systemic lupus erythematosus quality of life
- SLICC/ACR-DI:
-
systemic lupus international collaborating clinics/American College of Rheumatology – damage index
- SSC:
-
systemic lupus erythematosus symptom checklist
- UFPB:
-
universidade federal da paraíba
- UNIFESP:
-
Universidade Federal de São Paulo
References
Barr SG, Zonana-Nacach A, et al. (1999). Arthritis Rheum. 42(12): 2682–2688.
Beaton DE, Bombardier C, et al. (1998). Recommendations for Cross-Cultural Adaptations of Health Status Measures. American Academy of Orthopaedic Surgeons Institute for Work and Health.
Bombardier C, Gladman DD, et al. (1992). Arthritis Rheum. 35(6): 630–640.
Carr AJ. (1996). Br J Rheumatol. 35(10): 921–932.
Ciconelli R, Ferraz M, et al. (1999). Rev Bras Reumatol 39(3): 143–150.
D’Amorim AB. (2001). Avaliação das formas auto-administráveis dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. Tese de Mestrado. UNIFESP.
Fallowfield LJ. (1992). Eur J Cancer. 28A(Suppl 1): S39–S41.
Ferraz MB, Oliveira LM, et al. (1990). J Rheumatol. 17(6): 813–817.
Freire EA, Maia IO, et al. (2007). Clin Rheumatol. 26(3): 423–428.
Ginzler E, Berg A. (1987). J Rheumatol. Suppl 14(Suppl 13): 218–222.
Gladman D, Ginzler E, et al. (1992). Arthritis Rheum. 39(3): 363–369.
Gladman DD, Urowitz MB, et al. (1997). Arthritis Rheum. 40(5): 809–813.
Gladman DD, Goldsmith CH, et al. (2000). J Rheumatol. 27(2): 373–376.
Gladman DD, Ibanez D, et al. (2002). J Rheumatol. 29(2): 288–291.
Grootscholten C, Ligtenberg G, et al. (2003). Qual Life Res. 12(6): 635–644.
Guillemin F, Bombardier C, et al. (1993). J Clin Epidemiol. 46(12): 1417–1432.
Guyatt GH, Feeny DH, et al. (1993). Ann Intern Med. 118(8): 622–629.
Halioua B, Beumont MG, et al. (2000). Int J Dermatol. 39(11): 801–806.
Hay EM, Bacon PA, et al. (1993). Q J Med. 86(7): 447–458.
Hochberg MC, Boyd RE, et al. (1985). Medicine (Baltimore). 64(5): 285–295.
Isenberg DA, Rahman A, et al. (2005). BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic Iupus erythematosus. Rheumatology (Oxford). Jul; 44(7): 902–6. Epub 2005 Apr 6.
Kong KO, Ho HJ, et al. (2007). Arthritis Rheum. 57(6): 980–985.
Leong KP, Kong KO, et al. (2004). Ann Acad Med Singapore. 33(Suppl 5): S35–S37.
Leong KP, Kong KO, et al. (2005). Development and preliminary validation of systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford). Oct; 44(10): 1267–76. Epub 2005 Mar 29.
MacGowan JR, Ellis S, et al. (2002). Rheumatology (Oxford). 41(9): 981–987.
McElhone K, Abbot J, et al. (2007). Arthritis Rheum. 57(6): 972–979.
Moses N, Wiggers J, et al. (2007). Qual Life Res. 16(3): 461–466.
Pistiner M, Wallace DJ, et al. (1991). Semin Arthritis Rheum. 21(1): 55–64.
Sato EI, Ferraz M, et al. (1991). Rev Bras Reumatol. 31(4): 133–136.
Snoek FJ, Pouwer F, et al. (2000). Diabetes Care. 23(9): 305–309.
Swaak AJ, Nossent JC, et al. (1989). Ann Rheum Dis. 48(6): 447–454.
Testa MA. (1996). JAMA. 275(14): 1083; author reply 1084–1085.
Testa MA, Simonson DC. (1996). N Engl J Med. 334(13): 835–840.
Uribe AG, Vila LM, et al. (2004). J Rheumatol. 31(10): 1934–1940.
Ware JE Jr. (2007). Quality Metric Incorporated. SF-36. Health. Survey Update. SF-36.org.
Ware JE Jr, Bayliss MS, et al. (1996). JAMA. 276(13): 1039–1047.
Wilson IB, Kaplan S. (1995). Med Care. 33(Suppl 4): AS209–AS214.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Freire, E.A.M., Ciconelli, R.M. (2010). Translation, Cultural Adaptation and Validation of Health-Related Quality of Life Assessment Tools: A Brazilian Perspective on Patients with Systemic Lupus Erythematosus. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_190
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_190
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine